HomeImproved Vaccine Production
Improved Vaccine Production
LEARN HOW WE CAN TAKE YOUR INNOVATION from early phase development to full-scale GMP-manufacturing efficiently, safely, and cost-effectively
Contact us today to discuss your needs with a technical representative.
Fields indicated by an * are required.
Featured Articles
We are committed to partnering with pharmaceutical companies, organizations and other companies to accelerate vaccine development and ultimately increase access globally. Our collaborations with worldwide vaccine developers and researchers include:
- Leveraging previous efforts at an adenovirus-based vaccine platform for rapid development of a Covid-19 vaccine platform (read more)
- Building on previous collaborations with the Baylor College of Medicine to optimize production of two Covid-19 vaccine candidates (read more)
- Joining the DiViNe Consortium in Europe to address low yields and high costs of vaccine purification (read our white paper)
- Developing optimized purification processes with the International Vaccine Institute (read more)
- Receiving a grant from the Bill & Melinda Gates Foundation as part of a consortium pursuing a new manufacturing platform that would radically increase vaccine availability and affordability in developing countries (read more)
Contact us today to discuss your needs with a technical representative, and discover new solutions for better, faster, safer vaccine development.
Related Links
Natrix® Q Chromatography Membrane Adsorbers
A breakthrough in membrane chromatography
Fractogel® Ion Exchange Chromatography Resins
For Reliable and Effective Protein Purification
Benzonase®Endonuclease
Safety Plus Emprove® Expert
DNA and RNA Removal for downstream processing
Emprove® Chemicals Portfolio
Confidently fast track your new drug to market
ログインして続行
続きを確認するには、ログインするか、新規登録が必要です。
アカウントをお持ちではありませんか?